Category RSS Feed Posts by category Drug Science he https://www.mind-foundation.org/blog/he/category/category/drug-science/blog.category.xml Sat, 11 Jul 2026 10:50:07 +0200 Kick-off for a game with extra time: The EPIsoDE scientific symposium with an outlook on psychedelics in medical carehttps://www.mind-foundation.org/blog/he/symposium-episodeMon, 28 Oct 2024 13:57:15 +0100Henrik Jungaberlehttps://www.mind-foundation.org/blog/he/symposium-episode The APT Network - Building a Professional Community for Psychedelic Therapistshttps://www.mind-foundation.org/blog/he/the-apt-networkTue, 24 Sep 2024 12:06:13 +0200Max Wolffhttps://www.mind-foundation.org/blog/he/the-apt-networkDiscover how the MIND Foundation's Augmented Psychotherapy Training (APT) Network is creating a professional community for psychedelic therapists. With 142 members and growing, the network provides valuable support, collaboration, and development opportunities, advancing the integration of psychedelic therapy into mental health care worldwide. The Synthetic Toad – How to investigate 5-Meo-DMT in the labhttps://www.mind-foundation.org/blog/he/5-meo-dmt-syntheticThu, 28 Jul 2022 11:08:00 +0200Johannes ReckwegLukas A. Basedowhttps://www.mind-foundation.org/blog/he/5-meo-dmt-synthetic5-MeO-DMT & its effects: safety, dosage & therapeutic potential. Learn more in the interview with Johannes Reckweg! ► Read now! Field pharmacology and naturalistic placeboshttps://www.mind-foundation.org/blog/he/field-pharmacologyWed, 01 Dec 2021 09:26:00 +0100Malin Vedøy UthaugLucca Jaeckelhttps://www.mind-foundation.org/blog/he/field-pharmacologyEntdecken Sie die faszinierende Welt der Feld-Pharmakologie & wie naturalistische Placebos die psychedelische Therapie beeinflussen. ► Mehr erfahren! Tolerance to LSD – How the brain bolts the doors of perceptionhttps://www.mind-foundation.org/blog/he/tolerance-to-lsdSat, 16 Oct 2021 00:01:00 +0200Tobias Buchbornhttps://www.mind-foundation.org/blog/he/tolerance-to-lsdExplore the mechanisms and implications of LSD tolerance, including the role of glutamate receptors and the benefits and risks of long-term microdosing. How and why could MDMA-assisted psychotherapy treat PTSD?https://www.mind-foundation.org/blog/he/mdma-ptsdFri, 03 Sep 2021 16:40:00 +0200Samuli Kangaslampi, Ph.D.https://www.mind-foundation.org/blog/he/mdma-ptsdUnderstand PTSD, existing treatment strategies, and why MDMA-assisted psychotherapy holds such promise for treating patients with related symptoms. Leave the trips alonehttps://www.mind-foundation.org/blog/he/psychedelic-neuroscience-antidepressantFri, 25 Jun 2021 12:13:00 +0200Vlad Nicolescuhttps://www.mind-foundation.org/blog/he/psychedelic-neuroscience-antidepressantIs a "psychedelic trip" needed for the therapeutic benefits of psychedelics? Explore this controversy and a neuroscientific case arguing in favor. The future of psychedelics in Alzheimer’s disease treatmenthttps://www.mind-foundation.org/blog/he/psychedelics-alzheimers-disease-treatmentSat, 12 Jun 2021 01:52:00 +0200Milena Marinkovićhttps://www.mind-foundation.org/blog/he/psychedelics-alzheimers-disease-treatmentDiscover how psychedelics could offer new treatments for Alzheimer's disease and their potential impact on brain health and cognitive function. How do antidepressants really work?https://www.mind-foundation.org/blog/he/antidepressants-neurobiologyFri, 28 May 2021 16:09:00 +0200Lukas A. BasedowEero Castrénhttps://www.mind-foundation.org/blog/he/antidepressants-neurobiologyA new study takes a closer look at classic antidepressants like SSRIs & SNRIs. ► Read the interview with Prof. Castrén about antidepressants! Ascension, peak, returnhttps://www.mind-foundation.org/blog/he/psychedelic-phases-neuroscienceFri, 26 Mar 2021 13:40:00 +0100Dea Siggaard StenbækLukas A. Basedowhttps://www.mind-foundation.org/blog/he/psychedelic-phases-neuroscienceExplore how psychedelics affect brain function through different phases. Learn about their impact on consciousness from a neuroscience perspective.